Get started
Work

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2020-136384
Authors: Alex F. Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick B. Johnston, Matthew Mei, Leslie Popplewell, Saro H. Armenian, Thai Cao, Len Farol, Firoozeh Sahebi, Ricardo Spielberger, Robert Chen, Auayporn P. Nademanee, Lacolle Peters, Neena Kennedy, Steven T. Rosen, Larry W Kwak, Stephen J. Forman, Tatyana A. Feldman
Institutions: City Of Hope National Medical Center, City of Hope, The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, Mayo Clinic, Autolus (United Kingdom), Beckman Research Institute, Hackensack University Medical Center
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W3096417822
FWCI: 2.8
Cites:
Cited by: 20
Related to: 10